Kent Lake Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60,000
Closed -$2.41M 46
2021
Q4
$2.41M Buy
+60,000
New +$2.24M 1.25% 25
2021
Q2
Sell
-85,000
Closed -$3.54M 32
2021
Q1
$3.54M Sell
85,000
-20,000
-19% -$913K 1.44% 23
2020
Q4
$4.49M Buy
+105,000
New +$3.77M 2.12% 18

Other funds holding HALO

Kent Lake Capital's HALO Position: Q1 2022 in Review

Kent Lake Capital sold out of Halozyme (HALO) in Q1 2022, closing a stake of 60,000 shares — an estimated $2.41M sold.

Kent Lake Capital first reported a position in HALO in Q4 2020 and held it in 3 quarters. The position peaked at $4.49M in Q4 2020. 316 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

  • Kent Lake Capital reported no remaining Halozyme position as of Q1 2022 after selling out during the quarter.
  • Kent Lake Capital sold 60,000 Halozyme shares in Q1 2022, an estimated $2.41M.
  • Kent Lake Capital first reported a position in Halozyme in Q4 2020 and held it in 3 quarters.
  • Kent Lake Capital's Halozyme position peaked at $4.49M in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on Kent Lake Capital's 13F filing for Q1 2022, filed 16 May 2022.